SCHEMBL20652816

SCHEMBL20652816

Cc1ccc(-c2nc3c(c(=O)n(CCCO)c(=O)n3C(C)C)n2Cc2ccccc2)c(OCC2CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 3/20 0.42
▸ P2RX3 P56373 3/20 0.39
▸ BRAF P15056 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ PDE5A O76074 3/20 0.37
▸ PDE4A P27815 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ USP1 O94782 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KCNH2 Q12809 1/20 0.36
▸ TRPC4 Q9UBN4 1/20 0.36
▸ TRPC5 Q9UL62 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20652948 0.93 ADORA3 (0.41) ADORA3P2RX3BRAFPIK3CGRAB9A
SCHEMBL20653072 0.92 ADORA3 (0.42) ADORA3P2RX3BRAFPIK3CGRAB9A
SCHEMBL24095997 0.91 ADORA3 (0.42) ADORA3PDE5AMAPT
SCHEMBL20652815 0.89 ADORA3 (0.43) ADORA3P2RX3BRAFPIK3CGRAB9A
SCHEMBL20652961 0.88 ADORA3 (0.42) ADORA3P2RX3BRAFPIK3CGRAB9A
SCHEMBL20652947 0.88 ADORA3 (0.43) ADORA3P2RX3BRAFPIK3CGRAB9A
SCHEMBL20652805 0.87 P2RX3 (0.39) ADORA3P2RX3ALDH1A1MAPK1KCNH2
SCHEMBL20652803 0.86 P2RX3 (0.41) ADORA3P2RX3USP1KCNH2TRPC4
SCHEMBL20656216 0.86 P2RX3 (0.40) P2RX3PDE5AALDH1A1TP53TSHR
SCHEMBL20652804 0.86 P2RX3 (0.46) P2RX3ALDH1A1KDM4ETP53KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652176-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2021-12-15 — — EP disclosed
US-10329292-B2 Substituted xanthine derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-25 — — US disclosed
WO-2019011802-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — WO disclosed
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329292-B2 Substituted xanthine derivatives TRPC5, TRPV1, TRPC4 ADORA3 352/4885P2RX3 21/4885BRAF 1913/4885
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPV1 ADORA3 366/4885P2RX3 19/4885BRAF 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback